Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002993498 | SCV003292657 | likely benign | not provided | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002985715 | SCV003716141 | uncertain significance | Inborn genetic diseases | 2021-07-08 | criteria provided, single submitter | clinical testing | The c.931A>T (p.I311L) alteration is located in exon 9 (coding exon 8) of the SPTBN4 gene. This alteration results from a A to T substitution at nucleotide position 931, causing the isoleucine (I) at amino acid position 311 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV002993498 | SCV005386324 | uncertain significance | not provided | 2024-02-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |